National Clinical Guidelines aim to provide guidance and standards for improving the quality, safety and cost-effectiveness of healthcare in Ireland. They aim to promote healthcare that is current, effective and consistent, ensuring best outcomes for patients and people using services. To achieve this, they must be based on the best available scientific evidence of clinical benefits, cost-effectiveness, and they must consider the budget impact of their implementation.
The Health Research Board (HRB) is funding the Collaboration in Ireland for Clinical Effectiveness Reviews (CICER), which is hosted by HIQA. Following a competitive process, HIQA has been awarded research funding spanning the five-year period from 2017 to 2022 to produce the evidence to support the development of national clinical guidelines.
The HRB-CICER team comprises a dedicated multidisciplinary research team supported by staff from the Health Technology Assessment team in HIQA, the Discipline of Public Health and Primary Care in the School of Medicine at Trinity College Dublin (TCD), the Department of General Practice at the RCSI University of Medicine and Health Sciences, as well as national and international clinical and methodological experts.
The HRB-CICER team undertakes systematic reviews of the clinical effectiveness and cost-effectiveness of interventions included in the guidelines as well as estimating the budget impact of implementing the guidelines. The HRB-CICER team works closely with the guideline development groups to ensure that its work informs the development of evidence-based recommendations within the National Clinical Guidelines.